Allianz Asset Management
BSTC

Allianz Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Allianz Asset Management’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,197
Closed -$1.26M – 2616
2020
Q1 		$1.26M Sell
22,197
-52,031
-70% -$2.97M ﹤0.01% 1691
2019
Q4 		$4.23M Sell
74,228
-5,821
-7% -$309K ﹤0.01% 1559
2019
Q3 		$4.28M Sell
80,049
-33,985
-30% -$1.98M ﹤0.01% 1518
2019
Q2 		$6.81M Buy
114,034
+42,342
+59% +$2.66M 0.01% 1359
2019
Q1 		$4.47M Buy
71,692
+5,828
+9% +$386K ﹤0.01% 1519
2018
Q4 		$3.99M Sell
65,864
-4,001
-6% -$239K ﹤0.01% 1497
2018
Q3 		$4.09M Buy
69,865
+3,353
+5% +$171K ﹤0.01% 1652
2018
Q2 		$2.98M Buy
66,512
+693
+1% +$29.8K ﹤0.01% 1770
2018
Q1 		$2.92M Sell
65,819
-985
-1% -$41.4K ﹤0.01% 1761
2017
Q4 		$2.9M Sell
66,804
-18,097
-21% -$813K ﹤0.01% 1863
2017
Q3 		$3.95M Buy
84,901
+280
+0.3% +$13.4K ﹤0.01% 1734
2017
Q2 		$4.19M Buy
84,621
+18,026
+27% +$944K ﹤0.01% 1672
2017
Q1 		$3.65M Buy
66,595
+7,676
+13% +$406K ﹤0.01% 1761
2016
Q4 		$3.28M Sell
58,919
-7,576
-11% -$364K ﹤0.01% 1789
2016
Q3 		$3.04M Sell
66,495
-4,654
-7% -$187K ﹤0.01% 1824
2016
Q2 		$2.84M Sell
71,149
-2,742
-4% -$100K ﹤0.01% 1763
2016
Q1 		$2.57M Sell
73,891
-114,790
-61% -$4.21M ﹤0.01% 1704
2015
Q4 		$8.11M Sell
188,681
-27
-0% -$1.35K 0.01% 1151
2015
Q3 		$8.22M Buy
188,708
+97,860
+108% +$5.28M 0.01% 1070
2015
Q2 		$4.69M Buy
90,848
+5,278
+6% +$225K 0.01% 1404
2015
Q1 		$3.35M Buy
85,570
+31,293
+58% +$1.23M ﹤0.01% 1366
2014
Q4 		$2.1M Buy
54,277
+34,577
+176% +$1.32M ﹤0.01% 1538
2014
Q3 		$695K Buy
+19,700
New +$578K ﹤0.01% 1781

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allianz Asset Management's BSTC Position: Q2 2020 in Review

Allianz Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2020, closing a stake of 22,197 shares — an estimated $1.26M sold.

Allianz Asset Management first reported a position in BSTC in Q3 2014 and held it in 23 quarters. The position peaked at $8.22M in Q3 2015. 116 funds tracked by Wall St. Rank hold BSTC as of Q2 2020.

  • Allianz Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q2 2020 after selling out during the quarter.
  • Allianz Asset Management sold 22,197 BioSpecifics Technologies Corp. shares in Q2 2020, an estimated $1.26M.
  • Allianz Asset Management first reported a position in BioSpecifics Technologies Corp. in Q3 2014 and held it in 23 quarters.
  • Allianz Asset Management's BioSpecifics Technologies Corp. position peaked at $8.22M in Q3 2015.
  • 116 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2020.

Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.